AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Exploratory Study on Infection and Immunosenescence Based on an Elderly Clinical Cohort

Recruitingn/aAges 60 Years - anyAllHuashan Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This prospective observational cohort study aims to investigate the relationship between immunosenescence and infectious diseases in older adults. Individuals aged 60 years and older, including elderly patients with infections and healthy controls, will be enrolled and followed longitudinally. Clinical information, laboratory test results, and health assessment data will be collected. Biological specimens, including peripheral blood, urine, stool, sputum, and nasopharyngeal swabs, will be obtained during enrollment and follow-up. Participants will undergo regular assessments of health status, infection events, and aging-related clinical characteristics. The study will evaluate age-related changes in immune function, immune cell composition, immune receptor repertoires, epigenetic characteristics, metabolic profiles, and respiratory and gut microbiota. By integrating clinical and multi-

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria for the Healthy Control Group 1. No clinical symptoms suggestive of infection, including fever, cough, dyspnea, fatigue, or myalgia. 2. No abnormal physical signs, including lymphadenopathy, hepatomegaly, splenomegaly, or skin rash. 3. Normal laboratory test results, including complete blood count (CBC), C-reactive protein (CRP), and liver and renal function tests. 4. Healthy adults without underlying chronic diseases, no history of infectious diseases within the previous 6 months, and generally normal cognitive function. 5. Male or female. 6. Able to understand the study procedures and voluntarily provide written informed consent. Inclusion Criteria for the Infection Group 1.Age: 60 years or older; no gender restrictions. 2. Clinically diagnosed with an infectious disease by the treating physician. 3. The participant provides informed consent and signs the relevant documents. \-------------- Exclusion Criteria for the Healthy Control Group 1. Refusal to participate in the study; 2. Any other condition that, in the opinion of the investigator, makes the participant unsuitable for enrollment. Exclusion Criteria for the Infection Group 1. Final primary diagnosis is a non-infectious disease (e.g., connective tissue disease, tumor, or other conditions). 2. Positive culture results are determined by the clinician to be due to colonization or contamination rather than infection. 3. Refusal to participate in the study. 4. Patients in critical or severe conditions who are unable to cooperate with sample collection. 5. Other conditions deemed unsuitable for inclusion as determined by the researchers.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Huashan Hospital
Shanghai, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy